Immediate Impact
53 standout
Citing Papers
The interaction of innate immune and adaptive immune system
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Yogesh Jethava being referenced
Preliminary Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Subcutaneously (SC) Administered PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Yogesh Jethava | 246 | 197 | 146 | 50 | 405 | |
| H. Goldschmidt | 261 | 142 | 225 | 33 | 437 | |
| Marion Eveillard | 242 | 170 | 138 | 58 | 420 | |
| Satyajit Kosuri | 232 | 123 | 140 | 43 | 390 | |
| Shenglan Gong | 177 | 281 | 115 | 28 | 431 | |
| D. H. Cowan | 186 | 101 | 119 | 32 | 412 | |
| Yoshiaki Kuroda | 219 | 202 | 160 | 35 | 394 | |
| Iuliana Vaxman | 139 | 291 | 141 | 56 | 454 | |
| Chiara De Philippis | 301 | 127 | 123 | 43 | 421 | |
| Danai Dima | 163 | 154 | 206 | 66 | 351 | |
| Hyewon Lee | 210 | 123 | 147 | 38 | 406 |
All Works
Login with ORCID to disown or claim papers
Loading papers...